|
|
| 无锡药明康德新药开发股份有限公司- H股, 02359.HK - 财务比率 |
2023-12 |
2022-12 |
2021-12 |
2020-12 |
2019-12 |
2018-12 |
2017-12 |
2016-12 |
2015-12 |
| 变现能力分析 |
| 流动比率(倍) |
2.06 |
1.66 |
1.69 |
2.91 |
1.91 |
3.14 |
1.18 |
1.44 |
2.13 |
| 速动比率(倍) |
1.87 |
1.38 |
1.34 |
2.67 |
1.73 |
2.91 |
1.04 |
1.33 |
2.06 |
| 偿债能力分析 |
| 长期债项/股东权益(%) |
3.24 |
3.79 |
4.22 |
8.88 |
21.61 |
0.08 |
4.73 |
0.0 |
0.0 |
| 总债项/股东权益(%) |
10.43 |
12.54 |
10.67 |
13.21 |
32.89 |
0.76 |
25.51 |
8.79 |
5.11 |
| 总债项/资本运用(%) |
9.76 |
11.64 |
9.75 |
11.19 |
25.19 |
0.71 |
20.33 |
7.66 |
2.57 |
| 投资回报分析 |
| 股东权益回报率(%) |
19.39 |
18.91 |
13.23 |
9.09 |
10.71 |
12.78 |
19.35 |
17.51 |
10.36 |
| 资本运用回报率(%) |
18.15 |
17.55 |
12.08 |
7.7 |
8.2 |
11.96 |
15.41 |
15.26 |
5.21 |
| 总资产回报率(%) |
14.51 |
13.62 |
9.24 |
6.38 |
6.34 |
9.97 |
9.75 |
9.21 |
3.6 |
| 盈利能力分析 |
| 经营利润率(%) |
32.7 |
27.51 |
27.34 |
22.11 |
19.31 |
27.01 |
21.76 |
23.56 |
17.59 |
| 税前利润率(%) |
32.05 |
26.98 |
26.27 |
20.38 |
18.16 |
26.85 |
20.51 |
22.6 |
16.41 |
| 边际利润率(%) |
26.5 |
22.39 |
22.24 |
17.86 |
14.41 |
23.51 |
15.8 |
15.94 |
7.15 |
| 营运能力分析 |
| 存货周转率(倍) |
13.98 |
9.96 |
5.03 |
8.55 |
10.65 |
11.25 |
11.95 |
13.76 |
23.43 |
| 投资收益分析 |
| 派息比率(%) |
27.02 |
29.66 |
29.57 |
28.58 |
29.56 |
36.48 |
0.0 |
0.0 |
0.0 |
| 相关统计 |
| 财政年度周最高价 |
114.0 |
139.5 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
| 财政年度周最低价 |
59.5 |
57.9 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
| 财政年度最高市盈率(倍) |
28.57 |
41.08 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
| 财政年度最低市盈率(倍) |
14.91 |
17.05 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
| 财政年度最高周息率(%) |
1.81 |
1.74 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
| 财政年度最低周息率(%) |
0.95 |
0.72 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
0.0 |
|
|